Business Management Articles | Page 3

Surgery in Oncology Is Not Always a Simple Decision
The personalization of cancer care is more elaborately expressed in multidisciplinary tumor conferences and clinical trials.
The FDA has approved brentuximab vedotin (Adcetris) as a treatment for patients with cutaneous T-cell lymphoma who have received prior systemic therapy.
Finding the On-Ramp to Clinical Trial Offerings
Clinical trials help community practices attract patients, inspire oncologists, and lower costs, but forming a program can be daunting to the uninitiated.
Advance Planning Minimized Storm Impact for Oncology Practices
Texas Oncology and Florida Cancer Specialists (FCS) knew their ability to recover from hurricanes Harvey and Irma would hinge upon the work they did before either storm arrived.
Oncofertility is the specialty dealing with the clinical care of patients who will lose their fertility due to cancer treatment.
While providing information on the cancer and treatment gets a little easier with time, empathizing and accepting the emotions that patients and their families express does not.
The hood for handling biologics isn't vented to the outdoors, and there’s no negative-pressure room to safely contain and exhaust potentially tainted air.
Alternative payment models (APMs) are the future of Medicare payment.
The FDA has granted GSK2857916 a breakthrough therapy designation for patients with relapsed/refractory multiple myeloma.
CMS Reins in Spending Under 340B, Garnering Praise, Criticism
A newly announced CMS policy to redistribute savings under the 340B Drug Discount Program so that Medicare beneficiaries save money on copayments has garnered a mixture of praise and criticism from supporters and critics of the program.
Publication Bottom Border
Border Publication